AAM
FLGT icon

Advisors Asset Management’s Fulgent Genetics FLGT Stock Holding History

Advisors Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307K Buy
14,952
+4,473
+43% +$75.8K ﹤0.01% 1079
2026
Q1 		$167K Buy
10,479
+1,994
+24% +$43.3K ﹤0.01% 1182
2025
Q4 		$223K Buy
8,485
+8,117
+2,206% +$211K ﹤0.01% 1114
2025
Q3 		$8.32K Sell
368
-5
-1% -$103 ﹤0.01% 1387
2025
Q2 		$7.42K Sell
373
-11,366
-97% -$222K ﹤0.01% 1393
2025
Q1 		$198K Sell
11,739
-204
-2% -$3.48K ﹤0.01% 1108
2024
Q4 		$221K Sell
11,943
-819
-6% -$16K ﹤0.01% 1102
2024
Q3 		$277K Sell
12,762
-122
-0.9% -$2.73K 0.01% 1054
2024
Q2 		$253K Buy
12,884
+206
+2% +$4.3K ﹤0.01% 1053
2024
Q1 		$275K Sell
12,678
-247
-2% -$6.13K 0.01% 1072
2023
Q4 		$374K Buy
12,925
+4,336
+50% +$116K 0.01% 980
2023
Q3 		$230K Buy
8,589
+2,335
+37% +$79.7K ﹤0.01% 1078
2023
Q2 		$232K Buy
+6,254
New +$218K ﹤0.01% 1097

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Advisors Asset Management's FLGT Position: Q2 2026 in Review

Advisors Asset Management increased its Fulgent Genetics (FLGT) stake by 43% in Q2 2026, buying an estimated $75.8K and bringing the position to 14,952 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #1079.

Advisors Asset Management first reported a position in FLGT in Q2 2023 and has held it in 13 quarters since. The position peaked at $374K in Q4 2023. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Advisors Asset Management held 14,952 shares of Fulgent Genetics worth $307K as of Q2 2026.
  • Advisors Asset Management bought 4,473 Fulgent Genetics shares in Q2 2026, an estimated $75.8K.
  • Fulgent Genetics made up ﹤0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1079 holding.
  • Advisors Asset Management first reported a position in Fulgent Genetics in Q2 2023 and has held it in 13 quarters since.
  • Advisors Asset Management's Fulgent Genetics position peaked at $374K in Q4 2023.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.